Christiana Stamoulis' SEC Filing for Hologic Inc

The filing details the sale of 7,402 shares of common stock by Christiana Stamoulis, a director at Hologic Inc. The shares were acquired on October 20, 2025, through options granted on March 2, 2016. The sale is scheduled to occur on October 20, 2025, with an aggregate market value of $540,864.14. The transaction is being handled by Fidelity Brokerage Services LLC. There are no reported securities sold in the past three months. The filing was submitted on October 20, 2025, and the plan was adopted on February 19, 2025.